Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05321381 · ClinicalTrials.gov registry record · NA

Thriving Together: Supporting Resilience in the Healthcare Workforce

A NA study of Anxiety and Burnout, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
1,362
Enrollment target
2
Study locations

NCT05321381: Completed NA study of Anxiety and Burnout, sponsored by Johns Hopkins University.

NCT05321381 is a NA study of Anxiety and Burnout that has completed, run by Johns Hopkins University. The registered enrollment target is 1,362 participants, above the 436-participant average among 364 other Anxiety trials with a reported enrollment target (212% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05321381, a NA study of Anxiety and Burnout, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
1,362 participants
Enrollment target
2
Study locations

Study Summary

Health care workers (HCW) face distressing work related situations that pose a threat to the HCW's resilience and well-being. Hospital-based peer support programs can improve HCW well-being, but there are few programs and little data for settings outside of hospitals. The program would adapt, implement, and evaluate an evidence-informed peer support program (RISE) in ambulatory practices, rural hospitals, Federally Qualified Health Centers (FQHC), and community based organizations (CBOs). The hypothesis is that the availability of peer support will improve the culture of well-being, and the resilience and well-being of HCW in participating organizations. The research has the potential to improve the quality of life of HCW and the quality of care available to diverse organizations and the populations the HCW serve.

Primary Outcome

Score on 7-item scale to measure anxiety

Interventions

  • OTHER Resilience In Stressful Events (RISE) peer support team

Study Locations (2)

Maryland

  • Johns Hopkins Community Physicians - Baltimore
  • UM Shore Regional Health - Chestertown

Trial Details

FieldValue
Enrollment Target 1,362 participants
Start Date 2022-08-01
Est. Completion 2025-01-31
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT05321381 record still lists

NCT05321381 is an interventional study that assigns participants to a tested intervention. Its 1,362 participants enrollment target places it among the larger protocols in the corpus, above the 436-participant average among 364 other Anxiety trials with a reported enrollment target (212% higher).

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Resilience In Stressful Events (RISE) peer support team is the first listed.

NCT05321381 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05321381 about?

NCT05321381 is a clinical study titled "Thriving Together: Supporting Resilience in the Healthcare Workforce". Health care workers (HCW) face distressing work related situations that pose a threat to the HCW's resilience and well-being. Hospital-based peer support programs can improve HCW well-being, but there are few programs and little data for settings outside of hospitals. The program would adapt, implem...

What is the current status of trial NCT05321381?

This trial is currently completed. It is a NA study. The enrollment target is 1,362 participants. The study started on 2022-08-01. Estimated completion is 2025-01-31.

What conditions does trial NCT05321381 study?

This clinical trial studies the following conditions: Anxiety, Burnout, Emotional Distress.

What interventions are being tested in trial NCT05321381?

The interventions under investigation include: Resilience In Stressful Events (RISE) peer support team (OTHER).

Who is sponsoring clinical trial NCT05321381?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05321381 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05321381's enrollment target sits among peer trials

1,362 13th of 364 higher than 352 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02677064 · 1,365 participants

    Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

  • NCT04489238 · 1,366 participants

    Collection of Information to Better Understand Young Onset Colorectal Cancer

  • NCT05245227 · 1,358 participants · Phase 3

    Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

  • NCT07256392 · 1,370 participants · Phase 3

    Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05321381, the US trial registry maintained by the National Library of Medicine. NCT05321381 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.